오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - 45156 - medicine administration kit, percutaneous, medicated, single-use - adacel polio procedure pack contains a syringe pre-filled with a single dose of vaccine (pertussis vaccine - acellular diphtheria and tetanus toxoids (adsorbed) combined with inactivated poliovirus type 1,2 and 3 (vero cell)) and two separate needles of varying size. these separate needles are supplied to enable the vaccinator to choose the appropriate needle size for the injection of vaccine to the vaccinee. this is a single-use only product.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - 45156 - medicine administration kit, percutaneous, medicated, single-use - vivaxim procedure pack contains a syringe pre-filled with a single dose of vaccine (salmonella typhi vi polysaccharide and inactivated hepatitis a virus vaccine) and a separate needle for injection. this is a single-use only product.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - 45156 - medicine administration kit, percutaneous, medicated, single-use - avaxim is a vaccine indicated for active immunisation against hepatitis a infection in adults and children 2 years and over. each pack contains one dose of vaccine supsension in a pre-filled syringe without attached needle and two separate needles (16mm and 25mm) for administration.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - citric acid 0.384 g; glucose 1.62 g; potassium chloride 0.186 g; sodium bicarbonate 0.336 g; sodium chloride 0.117 g - effervescent tablet - active: citric acid 0.384 g glucose 1.62 g potassium chloride 0.186 g sodium bicarbonate 0.336 g sodium chloride 0.117 g excipient: lemon flavour powder 1013096 saccharin sodium

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - citric acid 0.384 g; glucose 1.62 g; potassium chloride 0.186 g; sodium bicarbonate 0.336 g; sodium chloride 0.117 g - effervescent tablet - active: citric acid 0.384 g glucose 1.62 g potassium chloride 0.186 g sodium bicarbonate 0.336 g sodium chloride 0.117 g excipient: raspberry flavour permaseal phs131990 saccharin sodium

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - pneumococcal polysaccharide serotype 1 25ug; pneumococcal polysaccharide serotype 10a 25ug; pneumococcal polysaccharide serotype 11a 25ug; pneumococcal polysaccharide serotype 12f 25ug; pneumococcal polysaccharide serotype 14 25ug; pneumococcal polysaccharide serotype 15b 25ug; pneumococcal polysaccharide serotype 17f 25ug; pneumococcal polysaccharide serotype 18c 25ug; pneumococcal polysaccharide serotype 19a 25ug; pneumococcal polysaccharide serotype 19f 25ug; pneumococcal polysaccharide serotype 2 25ug; pneumococcal polysaccharide serotype 20 25ug; pneumococcal polysaccharide serotype 22f 25ug; pneumococcal polysaccharide serotype 23f 25ug; pneumococcal polysaccharide serotype 3 25ug; pneumococcal polysaccharide serotype 33f 25ug; pneumococcal polysaccharide serotype 4 25ug; pneumococcal polysaccharide serotype 5 25ug; pneumococcal polysaccharide serotype 6b 25ug; pneumococcal polysaccharide serotype 7f 25ug; pneumococcal polysaccharide serotype 8 25ug; pneumococcal polysaccharide serotype 9n 25ug; pneumococcal polysaccharide serotype 9v 25ug - suspension for injection - 25 mcg - active: pneumococcal polysaccharide serotype 1 25ug pneumococcal polysaccharide serotype 10a 25ug pneumococcal polysaccharide serotype 11a 25ug pneumococcal polysaccharide serotype 12f 25ug pneumococcal polysaccharide serotype 14 25ug pneumococcal polysaccharide serotype 15b 25ug pneumococcal polysaccharide serotype 17f 25ug pneumococcal polysaccharide serotype 18c 25ug pneumococcal polysaccharide serotype 19a 25ug pneumococcal polysaccharide serotype 19f 25ug pneumococcal polysaccharide serotype 2 25ug pneumococcal polysaccharide serotype 20 25ug pneumococcal polysaccharide serotype 22f 25ug pneumococcal polysaccharide serotype 23f 25ug pneumococcal polysaccharide serotype 3 25ug pneumococcal polysaccharide serotype 33f 25ug pneumococcal polysaccharide serotype 4 25ug pneumococcal polysaccharide serotype 5 25ug pneumococcal polysaccharide serotype 6b 25ug pneumococcal polysaccharide serotype 7f 25ug pneumococcal polysaccharide serotype 8 25ug pneumococcal polysaccharide serotype 9n 25ug pneumococcal polysaccharide serotype 9v 25ug excipient: dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate phenol sodium chloride water for injection - pneumo 23 is indicated for high risk subjects 2 years of age and above to prevent pneumococcal pneumonia and systemic pneumococcal infections caused by the serotypes included in the vaccine.

싱가포르 - 영어 - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - carbocisteine - capsule - 375 mg

싱가포르 - 영어 - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - diphtheria toxoid protein; meningococcal (serogroup a) polysaccharide (monovalent conjugate); meningococcal (serogroup c) polysaccharide (monovalent conjugate); meningococcal (serogroup w-135) polysaccharide (monovalent conjugate); meningococcal (serogroup y) polysaccharide (monovalent conjugate) - injection, solution - 48 microgram (diptheria toxoid quantity is approximate and dependent on the conjugate polysaccharide to protein ratio) - diphtheria toxoid protein 48 mcg/dose (0.5 ml) (diphtheria toxoid quantity is approximate and dependent on the conjugate polysaccharide to protein ratio); meningococcal (serogroup a) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml); meningococcal (serogroup c) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml); meningococcal (serogroup w-135) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml); meningococcal (serogroup y) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml)

싱가포르 - 영어 - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - hepatitis a virus (inactivated) - injection, suspension - 80 antigen units - hepatitis a virus (inactivated) 80 antigen units

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - 45156 - medicine administration kit, percutaneous, medicated, single-use - hexaxim (diphtheria, tetanus, pertussis (acellular component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed) [dtpa-hepb-ipv-hib]) is indicated for vaccination of infants from 6 weeks of age against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and invasive infections caused by haemophilus influenzae type b. hexaxim consists of needleless pre-filled syringe containing the vaccine and 2 separate needles (25mm x 23g and 15mm x 25g) per syringe for administration.